Cue Biopharma Inc (CUE) Price Prediction & ForecastCUECue Biopharma Inc

Alphio's CUE stock price prediction model matches the current Cue Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.80 (-0.30%). The 1-week path is $27.50 (-1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Cue Biopharma Inc is a good buy right now, primarily driven by its recent revenue growth of 175.44% year-to-date and a current price of $27.88, which is significantly lower than its 52-week high of $45.50. The company's recent appointment of a new CFO and advancements in its clinical pipeline, including the upcoming Phase 2 data for CUE-221, indicate strong potential for future growth. However, the main risk is the recent net loss of $153.07 million in Q2 2026, which raises concerns about financial stability.

Cue Biopharma Inc (CUE) last closed at $27.88, losing -0.99%. These facts feed the 1-day and 1-week CUE price prediction above.